The pre-seed round was led by Science Creates Ventures with backing from a syndicate of institutional and angel investors.
"The UK would massively benefit from delivering major infrastructure projects on time and on budget, and through increased productivity by reducing the time it takes to bring such projects to the point of benefitting people. A big part of this is the difficulty found in mapping the complex unseen environments and hidden critical infrastructure that resides under the ground. Considerable budgets are allocated to ensure that unexpected obstacles can be overcome. On HS2 alone, the contingency for unforeseen ground conditions is £248m."
The photonics company has raised £12m in a Series A round led by Schlumberger to scale manufacturing of its greenhouse gas imaging technology.
"The technology is unique in the emissions monitoring marketplace in its potential to achieve the greatest amount of GHG abatement at the lowest cost of ownership,"
The seed round will fund team expansion and technology development ahead of commercial launches in the UK and US.
"Our vision is to enable people with Parkinson’s and other neurodegenerative diseases and movement disorders to live healthier lives. NuRO could give patients and clinicians a much clearer picture of their condition, enabling treatment to be tuned accurately as needed. We’re excited to continue our work with leading hospitals and patient groups and to bring our technology to market."
Parkwalk led the Series B financing, with participation from Meltwind, Newable Ventures and BGF, to widen access to the Censeo platform.
"The continued support from Parkwalk, Meltwind and BGF alongside new investment from Newable Ventures enables us to expand the reach of Censeo, helping more people who are struggling to find the right support for their mental health needs. We’re excited to grow our team, expand further across the NHS and demonstrate with our partners that our technology can make a substantial difference in the accuracy, consistency and efficiency of mental health assessments in a wide range of clinical settings."
